Atrion (ATRI) Hits New 12-Month High at $815.00

Atrion Co. (NASDAQ:ATRI) shares hit a new 52-week high during mid-day trading on Friday . The company traded as high as $815.00 and last traded at $814.57, with a volume of 12495 shares traded. The stock had previously closed at $802.30.

ATRI has been the topic of a number of analyst reports. BidaskClub upgraded shares of Atrion from a “hold” rating to a “buy” rating in a research report on Tuesday, January 1st. ValuEngine upgraded shares of Atrion from a “hold” rating to a “buy” rating in a research report on Monday, February 4th.

The stock has a market capitalization of $1.48 billion, a PE ratio of 43.30 and a beta of 0.43.

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 29th. Shareholders of record on Friday, March 15th will be given a dividend of $1.35 per share. The ex-dividend date is Thursday, March 14th. This represents a $5.40 dividend on an annualized basis and a dividend yield of 0.66%.

Large investors have recently made changes to their positions in the business. PNC Financial Services Group Inc. acquired a new position in shares of Atrion during the 4th quarter worth approximately $130,000. Amundi Pioneer Asset Management Inc. acquired a new position in shares of Atrion during the 4th quarter worth approximately $148,000. Quantamental Technologies LLC acquired a new position in shares of Atrion during the 4th quarter worth approximately $149,000. Legal & General Group Plc grew its position in shares of Atrion by 7.8% during the 4th quarter. Legal & General Group Plc now owns 249 shares of the medical instruments supplier’s stock worth $185,000 after purchasing an additional 18 shares in the last quarter. Finally, Jane Street Group LLC acquired a new position in shares of Atrion during the 4th quarter worth approximately $202,000. Hedge funds and other institutional investors own 61.74% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://sportsperspectives.com/2019/03/17/atrion-atri-hits-new-12-month-high-at-815-00.html.

About Atrion (NASDAQ:ATRI)

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.

Further Reading: P/E Growth (PEG)

Receive News & Ratings for Atrion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply